|Former Common name||Cfr KO|
|H-2 Haplotype||No Data|
|Strain description||No Data|
|Health Report||No Data|
|Symbol name||No Data|
|Common name||No Data|
|Symbol description||No Data|
|References||Development. 2010 Jan;137(1):159-67.
A novel regulatory mechanism for Fgf18 signaling involving cysteine-rich FGF receptor (Cfr) and delta-like protein (Dlk).
|Research applications||No Data|
|Specific Term and Conditions||The following terms and conditions will be requested by the DEPOSITOR.
In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested.
Development, 137, 159-167 (2010).
In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested.
For use of the BIOLOGICAL RESOURCE by a for-profit institution, the RECIPIENT must reach agreement on terms and conditions of use of it with DEPOSITOR and the founders of BayGenomics, and must obtain a prior written consent from the DEPOSITOR and the founders of BayGenomics.
|1||Lab HP (Japanese)|
|Depositor||Miyajima, Atsushi (The University of Tokyo)|
|Strain Status /
|A novel regulatory mechanism for Fgf18 signaling involving cysteine-rich FGF receptor (Cfr) and delta-like protein (Dlk).||Development.137(1): 159-67 (2010).(20023171)|
|Miyaoka Y, Tanaka M, Imamura T, Takada S, Miyajima A.|